ChronoScale Corporation Common Stock (CHRN) Financials

$25.71 -3.92 (-13.23%)

As of 04:00 PM Eastern

Annual Income Statements for ChronoScale Corporation Common Stock

This table shows ChronoScale Corporation Common Stock's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-24	-34	-29	-27	-12	-16	-9.76	-15	-15	-11	-12
Consolidated Net Income / (Loss)	-20	-23	-29	-27	-12	-16	-9.76	-15	-15	-11	-12
Net Income / (Loss) Continuing Operations	-20	-23	-29	-27	-12	-16	-9.76	-15	-15	-11	-12
Total Pre-Tax Income	-20	-23	-29	-27	-12	-16	-9.76	-15	-15	-11	-12
Total Operating Income	-22	-28	-32	-27	-17	-13	-14	-16	-15	-10	-13
Total Gross Profit	1.18	2.95	7.35	4.31	6.76	5.07	6.75	6.21	9.08	9.51	6.85
Total Revenue	8.66	14	7.35	11	14	8.88	11	13	18	18	13
Operating Revenue	8.66	14	7.35	11	14	8.88	11	13	18	18	13
Total Cost of Revenue	7.48	11	0.00	7.02	7.15	3.81	4.50	6.70	9.20	8.41	5.95
Operating Cost of Revenue	7.48	11	-	7.02	7.15	3.81	4.50	6.70	9.20	8.41	5.95
Total Operating Expenses	23	31	39	31	23	18	21	22	24	20	20
Selling, General & Admin Expense	7.00	11	11	12	7.41	7.70	11	11	11	8.79	9.99
Marketing Expense	9.26	11	13	14	11	7.75	7.31	7.16	8.47	7.31	7.15
Research & Development Expense	6.48	8.88	9.48	5.85	4.60	2.47	2.55	3.63	5.03	3.87	3.03
Total Other Income / (Expense), net	1.97	4.12	2.49	0.04	4.51	-2.53	4.06	0.48	-0.09	-0.87	1.63
Interest Expense	0.01	0.02	0.65	0.60	0.38	0.14	0.11	0.16	0.30	0.27	0.31
Other Income / (Expense), net	1.97	4.12	3.14	0.64	4.89	-2.40	4.18	0.63	0.22	-0.60	1.94
Basic Earnings per Share	($1.66)	($1.87)	($0.82)	($0.44)	($2.53)	($2.21)	($0.80)	($1.16)	($1.10)	($8.43)	($4.91)
Weighted Average Basic Shares Outstanding	14.61M	18.13M	35.61M	61.23M	4.79M	7.16M	12.19M	12.96M	13.87M	1.34M	2.43M
Weighted Average Diluted Shares Outstanding	14.61M	18.62M	35.61M	61.23M	4.79M	7.16M	12.27M	13.34M	17.90M	24.82M	3.56M
Weighted Average Basic & Diluted Shares Outstanding	14.60M	21.90M	35.61M	61.23M	4.79M	7.16M	12.69M	13.34M	17.90M	24.82M	3.56M

This table shows ChronoScale Corporation Common Stock's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-3.37	-3.21	-3.43	-2.42	-2.07	-3.41	-2.89	-2.71	-1.42	-4.67	-6.89
Consolidated Net Income / (Loss)	-3.37	-3.21	-3.43	-2.42	-2.07	-3.41	-2.89	-2.71	-1.42	-4.67	-6.89
Net Income / (Loss) Continuing Operations	-3.37	-3.30	-3.43	-2.42	-2.07	-3.41	-2.89	-2.71	-1.42	-4.67	-6.89
Total Pre-Tax Income	-3.37	-3.21	-3.43	-2.42	-2.07	-3.41	-2.89	-2.71	-1.42	-4.67	-6.89
Total Operating Income	-2.93	-3.45	-3.26	-2.34	-2.64	-2.23	-3.44	-3.98	-1.40	-4.51	-5.62
Total Gross Profit	2.46	2.37	1.95	2.64	2.21	2.71	1.81	0.82	2.55	1.67	1.07
Total Revenue	4.61	4.85	3.76	4.95	4.13	5.09	3.38	2.06	4.23	3.14	2.14
Operating Revenue	4.61	4.85	3.76	4.95	4.13	5.09	3.38	2.06	4.23	3.14	2.14
Total Cost of Revenue	2.15	2.48	1.81	2.31	1.92	2.38	1.57	1.24	1.68	1.47	1.07
Operating Cost of Revenue	2.15	2.48	1.81	2.31	1.92	2.38	1.57	1.24	1.68	1.47	1.07
Total Operating Expenses	5.39	5.82	5.21	4.97	4.85	4.94	5.25	4.79	3.95	6.18	6.69
Selling, General & Admin Expense	2.18	2.52	2.25	2.01	2.31	2.22	2.55	2.25	2.09	3.10	4.06
Marketing Expense	2.05	1.98	1.82	1.85	1.76	1.88	1.71	1.69	1.31	2.44	2.05
Research & Development Expense	1.16	1.31	1.14	1.12	0.78	0.85	0.99	0.85	0.55	0.64	0.58
Total Other Income / (Expense), net	-0.43	0.24	-0.17	-0.08	0.57	-1.18	0.55	1.27	-0.02	-0.17	-1.27
Interest Expense	0.06	0.07	0.06	0.07	0.08	0.06	0.07	0.07	0.02	0.15	0.14
Other Income / (Expense), net	-0.37	0.30	-0.12	-0.01	0.65	-1.12	0.62	1.33	-0.00	-0.01	-1.12
Basic Earnings per Share	($0.24)	($0.22)	($0.20)	($1.99)	($1.53)	($2.54)	($1.84)	($1.24)	($0.54)	($1.93)	($2.04)
Weighted Average Basic Shares Outstanding	14.07M	13.87M	17.42M	1.22M	1.35M	1.34M	1.69M	2.18M	2.62M	2.43M	3.56M
Weighted Average Diluted Shares Outstanding	14.23M	17.90M	18.17M	18.44M	22.00M	24.82M	29.04M	2.61M	2.62M	3.56M	3.56M
Weighted Average Basic & Diluted Shares Outstanding	14.23M	17.90M	18.17M	18.44M	22.00M	24.82M	29.04M	2.61M	2.62M	3.56M	3.56M

This table details how cash moves in and out of ChronoScale Corporation Common Stock's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-5.64	-2.71	11	-20	3.22	1.99	28	-20	-12	-2.15	-5.32
Net Cash From Operating Activities	-18	-25	-31	-22	-16	-8.76	-11	-15	-12	-9.85	-12
Net Cash From Continuing Operating Activities	-18	-25	-31	-22	-16	-8.76	-11	-15	-12	-9.85	-12
Net Income / (Loss) Continuing Operations	-20	-23	-29	-27	-12	-16	-9.76	-15	-15	-11	-12
Consolidated Net Income / (Loss)	-20	-23	-29	-27	-12	-16	-9.76	-15	-15	-11	-12
Depreciation Expense	0.93	1.86	1.75	1.52	0.69	0.62	1.02	0.89	1.70	1.61	1.57
Non-Cash Adjustments To Reconcile Net Income	-0.20	-1.18	-0.28	2.63	-2.38	5.33	-1.49	2.09	2.03	2.40	0.36
Changes in Operating Assets and Liabilities, net	0.62	-2.16	-3.58	0.53	-1.95	1.12	-0.93	-2.58	-0.58	-2.53	-2.04
Net Cash From Investing Activities	-1.49	-1.10	-0.46	-0.13	-0.06	0.00	-0.06	-5.18	-0.16	-0.04	-0.19
Net Cash From Continuing Investing Activities	-1.49	-1.10	-0.46	-0.13	-0.06	0.00	-0.06	-5.18	-0.16	-0.04	-0.19
Purchase of Property, Plant & Equipment	-1.49	-1.10	-0.46	-0.13	-0.06	0.00	-0.06	-0.19	-0.16	-0.04	-0.19
Net Cash From Financing Activities	14	23	43	2.27	19	11	39	0.00	0.35	7.77	6.63
Net Cash From Continuing Financing Activities	14	23	43	2.27	19	11	39	0.00	0.35	7.77	6.63
Repayment of Debt	-0.06	-0.08	-	-2.17	-2.38	-2.79	-	0.00	-0.31	-1.25	-3.25
Issuance of Debt	-	6.93	0.05	-	0.00	3.08	-	-	-	0.00	1.93
Issuance of Common Equity	0.00	15	42	4.45	21	7.08	37	0.00	0.66	9.02	4.10
Other Financing Activities, net	0.28	1.94	0.16	0.00	0.23	3.33	1.42	-	-	0.00	3.86
Other Net Changes in Cash	-	-	-	-	-	-	-	-	-	-	0.04
Cash Interest Paid	0.01	0.03	0.02	0.02	0.02	0.01	0.00	0.13	0.19	0.18	0.12
Cash Income Taxes Paid	0.01	0.02	0.43	0.46	0.31	0.11	0.10	0.01	0.05	0.01	0.01

This table details how cash moves in and out of ChronoScale Corporation Common Stock's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-3.37	-1.30	0.16	-2.91	2.41	-1.80	1.56	-2.81	-2.52	-1.55	2.82
Net Cash From Operating Activities	-3.35	-1.58	-3.47	-2.67	-2.28	-1.43	-1.97	-3.44	-2.06	-4.33	-2.12
Net Cash From Continuing Operating Activities	-3.35	-1.58	-3.47	-2.67	-2.28	-1.43	-1.97	-3.44	-2.06	-4.33	-2.12
Net Income / (Loss) Continuing Operations	-3.37	-3.21	-3.43	-2.42	-2.07	-3.41	-2.89	-2.71	-1.42	-4.67	-6.89
Consolidated Net Income / (Loss)	-3.37	-3.21	-3.43	-2.42	-2.07	-3.41	-2.89	-2.71	-1.42	-4.67	-6.89
Depreciation Expense	0.42	0.43	0.41	0.40	0.41	0.40	0.38	0.38	0.37	0.45	0.45
Non-Cash Adjustments To Reconcile Net Income	0.91	0.28	0.51	0.43	-0.14	1.61	-0.20	-1.11	0.28	1.39	1.64
Changes in Operating Assets and Liabilities, net	-1.32	0.91	-0.95	-1.08	-0.47	-0.03	0.75	-0.01	-1.29	-1.50	2.67
Net Cash From Investing Activities	-0.02	-0.04	-0.01	-	-0.01	-0.02	-0.01	-0.04	-0.01	-0.13	0.00
Net Cash From Continuing Investing Activities	-0.02	-0.04	-0.01	-	-0.01	-0.02	-0.01	-0.04	-0.01	-0.13	0.00
Purchase of Property, Plant & Equipment	-0.02	-0.04	-0.01	-	-0.01	-0.02	-0.01	-0.04	-0.01	-0.13	0.00
Net Cash From Financing Activities	-	0.35	3.66	-0.27	4.69	-0.31	3.53	0.62	-0.44	2.92	4.95
Net Cash From Continuing Financing Activities	-	0.35	3.66	-0.27	4.69	-0.31	3.53	0.62	-0.44	2.92	4.95
Repayment of Debt	-	-0.31	-0.31	-0.31	-0.31	-0.31	-0.31	-0.31	-2.31	-0.31	-0.31
Repurchase of Preferred Equity	-	-	-	-	-	-	0.00	-	-	-	5.27
Other Financing Activities, net	-	-	0.00	-	-	-	3.84	0.01	-	-	0.00
Effect of Exchange Rate Changes	-	-0.02	-	-	0.00	-0.03	0.01	-	-	-	-0.01
Cash Interest Paid	0.05	0.05	0.05	0.05	0.05	0.04	0.04	0.04	0.03	-	0.00
Cash Income Taxes Paid	0.00	0.01	0.00	0.01	0.00	-0.00	0.00	0.00	0.00	-	0.00

This table presents ChronoScale Corporation Common Stock's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	32	24	38	18	22	21	49	41	29	27	20
Total Current Assets	25	21	35	15	19	18	48	31	20	19	14
Cash & Equivalents	20	17	28	7.66	11	13	-	21	8.64	4.49	1.17
Accounts Receivable	2.07	1.78	2.76	3.66	5.21	3.22	4.66	4.63	5.65	7.24	7.31
Inventories, net	1.06	1.56	3.03	3.37	2.49	1.98	2.24	5.19	5.05	4.57	4.82
Prepaid Expenses	0.44	0.50	1.34	0.28	0.24	0.36	0.49	0.70	0.88	0.54	0.75
Plant, Property, & Equipment, net	2.63	2.44	2.25	2.37	1.66	1.17	0.99	2.68	2.02	1.58	1.29
Total Noncurrent Assets	4.37	1.31	0.80	0.32	1.45	1.01	0.38	7.19	6.69	6.23	4.77
Goodwill	0.19	0.19	0.19	0.19	0.19	-	0.00	0.43	0.43	0.43	0.43
Intangible Assets	1.58	1.03	0.49	-	-	-	0.00	5.22	4.89	4.58	3.50
Other Noncurrent Operating Assets	2.60	0.09	0.12	0.13	1.26	1.01	0.38	1.54	1.37	1.22	0.84
Total Liabilities & Shareholders' Equity	32	24	38	18	22	21	49	41	29	27	20
Total Liabilities	23	18	17	15	15	16	12	15	16	14	11
Total Current Liabilities	8.62	6.33	9.17	10	7.83	4.97	6.86	9.20	8.12	7.54	8.64
Short-Term Debt	0.08	0.00	2.14	2.33	2.33	-	0.00	2.31	1.25	1.25	3.26
Accounts Payable	2.69	2.37	2.42	3.16	1.90	1.50	3.11	3.15	1.85	1.55	1.43
Accrued Expenses	1.89	3.13	3.50	3.49	1.68	1.43	2.30	2.28	2.66	2.35	1.78
Current Deferred Revenue	3.96	0.83	1.10	1.10	1.49	1.50	1.22	1.12	1.99	1.96	1.73
Other Current Liabilities	-	-	-	-	0.42	0.55	0.23	0.34	0.36	0.43	0.44
Total Noncurrent Liabilities	15	12	7.43	4.85	7.29	11	5.09	6.26	8.20	6.41	2.45
Long-Term Debt	0.00	6.79	4.83	2.65	0.41	3.08	1.99	3.77	4.83	3.85	0.80
Noncurrent Deferred Revenue	4.61	0.81	0.82	1.50	1.79	1.81	1.48	1.03	2.17	1.92	1.41
Other Noncurrent Operating Liabilities	10	3.97	1.79	0.70	5.09	6.31	1.62	1.46	1.19	0.63	0.24
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	-	-	0.00
Total Equity & Noncontrolling Interests	8.81	6.53	21	2.73	6.80	4.43	37	25	13	13	9.03
Total Preferred & Common Equity	8.81	6.53	21	2.73	6.80	4.43	37	25	13	13	9.03
Total Common Equity	8.81	6.53	21	2.73	6.80	4.43	37	25	13	13	9.03
Common Stock	100	121	166	174	190	204	246	249	252	262	272
Retained Earnings	-91	-115	-144	-171	-183	-199	-209	-224	-239	-250	-262
Accumulated Other Comprehensive Income / (Loss)	-0.00	0.08	-0.34	-0.09	0.05	-0.85	-0.02	0.56	0.16	0.96	-0.69

This table presents ChronoScale Corporation Common Stock's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	31	29	27	29	27	23	22	20
Total Current Assets	22	21	19	21	20	16	15	14
Cash & Equivalents	9.94	8.80	5.89	8.29	8.05	5.24	2.72	3.99
Accounts Receivable	5.87	5.77	6.52	6.96	6.46	4.53	6.05	4.54
Inventories, net	5.49	5.11	4.97	5.03	4.96	5.44	5.02	4.65
Prepaid Expenses	1.07	0.84	1.26	0.78	0.60	0.76	1.00	0.87
Plant, Property, & Equipment, net	2.09	1.86	1.75	1.63	1.45	1.44	1.24	1.12
Total Noncurrent Assets	6.74	6.58	6.59	6.52	5.79	5.76	5.63	4.50
Goodwill	0.43	0.43	0.43	0.43	0.43	0.43	0.43	0.43
Intangible Assets	4.97	4.82	4.74	4.66	4.32	4.24	4.15	3.42
Other Noncurrent Operating Assets	1.33	1.33	1.42	1.42	1.04	1.09	1.05	0.65
Total Liabilities & Shareholders' Equity	31	29	27	29	27	23	22	20
Total Liabilities	16	15	15	14	15	12	12	14
Total Current Liabilities	7.83	7.31	7.70	7.51	8.55	6.71	8.94	9.09
Short-Term Debt	1.25	1.25	1.25	1.25	1.25	1.25	3.19	3.33
Accounts Payable	2.50	1.88	2.13	1.81	2.00	1.45	1.66	2.11
Accrued Expenses	2.10	1.79	1.97	1.98	2.97	1.76	1.93	1.72
Current Deferred Revenue	1.64	2.03	1.93	2.04	1.91	1.81	1.70	1.58
Other Current Liabilities	0.35	0.37	0.43	0.43	0.43	0.45	0.46	0.35
Total Noncurrent Liabilities	8.09	7.59	7.22	6.83	6.07	5.52	3.04	4.84
Long-Term Debt	5.07	4.59	4.35	4.11	3.60	3.34	1.07	0.52
Noncurrent Deferred Revenue	2.06	2.12	2.02	1.97	1.96	1.69	1.63	1.26
Other Noncurrent Operating Liabilities	0.96	0.88	0.85	0.76	0.51	0.50	0.34	3.06
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	3.65
Total Equity & Noncontrolling Interests	15	14	12	15	13	11	9.68	2.09
Total Preferred & Common Equity	15	14	12	15	13	11	9.68	2.09
Total Common Equity	15	14	12	15	13	11	9.68	2.09
Common Stock	250	256	257	262	266	268	268	272
Retained Earnings	-236	-243	-245	-247	-254	-256	-258	-269
Accumulated Other Comprehensive Income / (Loss)	0.73	0.45	0.54	0.01	0.42	-0.68	-0.70	-0.48

This table displays calculated financial ratios and metrics derived from ChronoScale Corporation Common Stock's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	62.59%	64.20%	-48.29%	54.11%	22.81%	-36.18%	26.62%	14.81%	41.57%	-1.94%	-28.60%
EBITDA Growth	42.35%	-15.81%	-23.46%	7.49%	55.28%	-36.25%	42.73%	-62.69%	5.98%	28.38%	-3.81%
EBIT Growth	41.25%	-19.80%	-21.34%	7.31%	55.49%	-33.52%	38.47%	-54.64%	0.19%	25.75%	-2.94%
NOPAT Growth	-28.39%	-27.94%	-14.59%	14.49%	38.44%	20.12%	-4.04%	-12.50%	2.85%	30.78%	-27.40%
Net Income Growth	41.99%	-19.81%	-24.08%	7.31%	55.05%	-30.44%	38.30%	-54.44%	-0.78%	25.45%	-3.22%
EPS Growth	39.40%	-12.02%	60.00%	46.34%	55.05%	12.65%	60.18%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	-21.74%	-36.83%	-24.92%	29.02%	28.84%	44.49%	-27.42%	-31.66%	17.93%	18.32%	-19.86%
Free Cash Flow Firm Growth	42.04%	-290.22%	0.93%	29.67%	44.33%	48.47%	-161.81%	-66.76%	58.25%	10.84%	-15.53%
Invested Capital Growth	-353.98%	66.94%	115.51%	-90.13%	-2,572.22%	-300.97%	77.69%	1,020.77%	-8.59%	12.62%	5.27%
Revenue Q/Q Growth	5.65%	4.74%	-1.79%	8.05%	3.13%	-14.18%	11.57%	1.03%	7.63%	1.37%	-13.22%
EBITDA Q/Q Growth	45.38%	-3.44%	-14.16%	16.46%	9.61%	-12.80%	29.75%	-19.78%	1.04%	-2.59%	-12.79%
EBIT Q/Q Growth	44.14%	-4.05%	-12.75%	15.43%	10.27%	-12.11%	26.99%	-18.55%	-0.24%	-1.89%	-11.41%
NOPAT Q/Q Growth	-9.07%	-0.11%	-4.17%	9.41%	12.14%	-1.20%	-3.42%	-6.74%	6.13%	10.44%	-20.63%
Net Income Q/Q Growth	44.19%	-4.13%	-13.23%	15.23%	10.41%	-8.61%	17.44%	-9.16%	-0.24%	-1.79%	-12.09%
EPS Q/Q Growth	32.97%	16.67%	-10.81%	15.38%	10.41%	-79.67%	31.78%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-15.68%	2.89%	-4.00%	2.16%	18.83%	-2.88%	-13.59%	-4.03%	14.60%	1.51%	-32.55%
Free Cash Flow Firm Q/Q Growth	73.02%	-60.56%	9.34%	-16.20%	38.94%	-18.62%	-37.78%	-64.64%	55.14%	-1.38%	-41.51%
Invested Capital Q/Q Growth	-531.75%	21.73%	-82.65%	102.88%	-180.04%	-74.42%	49.94%	668.81%	-13.63%	-5.16%	6.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	13.61%	20.72%	100.00%	38.03%	48.60%	57.08%	60.01%	48.13%	49.67%	53.06%	53.48%
EBITDA Margin	-215.82%	-152.22%	-363.47%	-218.19%	-79.46%	-169.62%	-76.72%	-108.71%	-72.20%	-52.74%	-76.67%
Operating Margin	-248.94%	-193.98%	-429.92%	-238.53%	-119.56%	-149.64%	-122.96%	-120.48%	-82.67%	-58.35%	-104.12%
EBIT Margin	-226.16%	-165.01%	-387.24%	-232.90%	-84.41%	-176.60%	-85.82%	-115.58%	-81.49%	-61.71%	-88.96%
Profit (Net Income) Margin	-226.19%	-165.04%	-396.06%	-238.19%	-87.17%	-178.17%	-86.82%	-116.79%	-83.14%	-63.21%	-91.37%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	100.01%	100.02%	102.28%	102.27%	103.27%	100.89%	101.17%	101.05%	102.03%	102.43%	102.71%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	-6,296.51%	0.00%	0.00%	0.00%	-222.23%	-100.54%	-68.53%	-80.30%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	-6,227.87%	0.00%	0.00%	0.00%	-206.37%	-46.20%	134.66%	-396.30%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	6,072.68%	0.00%	0.00%	0.00%	174.10%	20.65%	-20.99%	-27.31%
Return on Equity (ROE)	-123.96%	-306.02%	-208.60%	-223.82%	-254.74%	-281.81%	-46.88%	-48.13%	-79.89%	-89.52%	-107.62%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-4,790.02%	-6,132.45%	0.00%	0.00%	0.00%	-209.91%	-91.56%	-80.40%	-85.44%
Operating Return on Assets (OROA)	-59.65%	-82.89%	-91.24%	-94.86%	-59.38%	-73.80%	-27.67%	-33.14%	-42.67%	-39.81%	-48.70%
Return on Assets (ROA)	-59.66%	-82.90%	-93.32%	-97.02%	-61.32%	-74.45%	-27.99%	-33.49%	-43.53%	-40.78%	-50.02%
Return on Common Equity (ROCE)	-123.96%	-306.02%	-208.60%	-223.82%	-254.74%	-281.81%	-46.88%	-48.13%	-79.89%	-89.52%	-107.62%
Return on Equity Simple (ROE_SIMPLE)	-222.41%	-359.36%	-136.14%	-989.44%	-178.49%	-356.90%	-26.23%	-59.27%	-120.56%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-15	-19	-22	-19	-12	-9.30	-9.68	-11	-11	-7.32	-9.33
NOPAT Margin	-174.26%	-135.79%	-300.94%	-166.97%	-83.69%	-104.75%	-86.07%	-84.33%	-57.87%	-40.85%	-72.88%
Net Nonoperating Expense Percent (NNEP)	-20.16%	-28.17%	-45.26%	-68.64%	-8.97%	-72.79%	-0.35%	-15.86%	-54.34%	-203.19%	315.99%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-56.61%	-41.11%	-71.30%
Cost of Revenue to Revenue	86.39%	79.28%	0.00%	61.97%	51.40%	42.92%	39.99%	51.87%	50.33%	46.94%	46.52%
SG&A Expenses to Revenue	80.85%	76.32%	145.72%	102.94%	53.24%	86.71%	95.35%	85.09%	58.50%	49.03%	78.02%
R&D to Revenue	74.82%	62.44%	128.97%	51.60%	33.02%	27.85%	22.67%	28.08%	27.49%	21.61%	23.68%
Operating Expenses to Revenue	262.56%	214.70%	529.92%	276.55%	168.16%	206.72%	182.97%	168.60%	132.34%	111.41%	157.60%
Earnings before Interest and Taxes (EBIT)	-20	-23	-28	-26	-12	-16	-9.65	-15	-15	-11	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-19	-22	-27	-25	-11	-15	-8.63	-14	-13	-9.45	-9.81
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	17.16	13.33	5.96	28.47	4.31	11.50	0.90	0.61	2.82	1.06	2.51
Price to Tangible Book Value (P/TBV)	21.49	16.38	6.16	30.59	4.44	11.50	0.90	0.79	4.89	1.74	4.45
Price to Revenue (P/Rev)	17.45	6.12	17.35	6.85	2.11	5.74	2.98	1.21	1.95	0.75	1.77
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	195.16	1,388.93	0.00	0.00	0.00	0.11	3.29	1.06	2.14
Enterprise Value to Revenue (EV/Rev)	15.21	5.42	14.52	6.62	1.52	4.64	0.00	0.09	1.81	0.67	2.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	1.04	0.33	1.83	0.40	0.69	0.05	0.24	0.48	0.40	0.45
Long-Term Debt to Equity	0.00	1.04	0.23	0.97	0.06	0.69	0.05	0.15	0.38	0.30	0.09
Financial Leverage	-1.41	-1.93	-1.11	-0.98	-1.13	-1.60	-1.16	-0.84	-0.45	-0.16	0.07
Leverage Ratio	2.08	3.69	2.24	2.31	4.15	3.79	1.67	1.44	1.84	2.20	2.15
Compound Leverage Factor	2.08	3.69	2.29	2.36	4.29	3.82	1.69	1.45	1.87	2.25	2.21
Debt to Total Capital	0.90%	50.97%	24.57%	64.61%	28.73%	40.95%	5.08%	19.28%	32.54%	28.66%	31.00%
Short-Term Debt to Total Capital	0.90%	0.00%	7.54%	30.26%	24.46%	0.00%	0.00%	7.33%	6.69%	7.02%	24.90%
Long-Term Debt to Total Capital	0.00%	50.97%	17.03%	34.35%	4.27%	40.95%	5.08%	11.95%	25.86%	21.64%	6.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.10%	49.03%	75.43%	35.39%	71.27%	59.05%	94.92%	80.72%	67.46%	71.34%	69.00%
Debt to EBITDA	0.00	-0.31	-0.26	-0.20	-0.25	-0.20	-0.23	-0.43	-0.46	-0.54	-0.41
Net Debt to EBITDA	1.04	0.46	0.78	0.11	0.74	0.65	4.45	1.03	0.19	0.15	-0.29
Long-Term Debt to EBITDA	0.00	-0.31	-0.18	-0.11	-0.04	-0.20	-0.23	-0.27	-0.37	-0.41	-0.08
Debt to NOPAT	-0.01	-0.35	-0.31	-0.26	-0.24	-0.33	-0.21	-0.56	-0.57	-0.70	-0.43
Net Debt to NOPAT	1.29	0.52	0.94	0.14	0.70	1.05	3.97	1.33	0.24	0.19	-0.31
Long-Term Debt to NOPAT	0.00	-0.35	-0.22	-0.14	-0.03	-0.33	-0.21	-0.35	-0.46	-0.53	-0.09
Altman Z-Score	-1.22	-5.55	-2.17	-14.41	-11.08	-12.94	-3.68	-7.31	-10.83	-12.77	-17.95
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.92	3.27	3.81	1.48	2.40	3.70	6.97	3.37	2.49	2.50	1.63
Quick Ratio	2.51	2.94	3.34	1.12	2.05	3.23	0.68	2.73	1.76	1.56	0.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-6.78	-26	-26	-18	-10	-5.29	-14	-23	-9.63	-8.59	-9.92
Operating Cash Flow to CapEx	-1,224.46%	-2,280.75%	-6,847.81%	-16,919.85%	-26,286.67%	0.00%	-18,908.47%	-8,393.14%	-7,677.71%	-26,610.81%	-6,277.13%
Free Cash Flow to Firm to Interest Expense	-521.36	-1,653.01	-40.43	-30.71	-26.71	-38.03	-122.47	-147.93	-31.90	-31.93	-32.12
Operating Cash Flow to Interest Expense	-1,405.31	-1,562.31	-48.19	-36.94	-41.07	-62.99	-98.73	-94.15	-39.91	-36.60	-38.19
Operating Cash Flow Less CapEx to Interest Expense	-1,520.08	-1,630.81	-48.89	-37.16	-41.23	-62.99	-99.25	-95.28	-40.43	-36.74	-38.80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.26	0.50	0.24	0.41	0.70	0.42	0.32	0.29	0.52	0.65	0.55
Accounts Receivable Turnover	4.79	7.39	3.24	3.53	3.14	2.11	2.85	2.78	3.56	2.78	1.76
Inventory Turnover	8.92	8.63	0.00	2.20	2.44	1.71	2.13	1.80	1.80	1.75	1.27
Fixed Asset Turnover	3.66	5.62	3.14	4.91	6.92	6.28	10.40	7.03	7.78	9.97	8.93
Accounts Payable Turnover	4.30	4.45	0.00	2.52	2.83	2.24	1.95	2.14	3.68	4.95	3.99
Days Sales Outstanding (DSO)	76.24	49.39	112.68	103.39	116.29	173.25	127.97	131.26	102.54	131.17	207.41
Days Inventory Outstanding (DIO)	40.93	42.28	0.00	166.21	149.51	213.86	171.26	202.42	203.07	208.68	287.91
Days Payable Outstanding (DPO)	84.81	82.04	0.00	144.90	129.07	162.97	187.00	170.51	99.15	73.72	91.43
Cash Conversion Cycle (CCC)	32.36	9.64	112.68	124.70	136.73	224.15	112.23	163.17	206.46	266.12	403.89
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-11	-3.53	0.55	0.05	-1.34	-5.35	-1.19	11	10	11	12
Invested Capital Turnover	-1.33	-2.00	-4.94	37.71	-21.73	-2.66	-3.44	2.64	1.74	1.68	1.10
Increase / (Decrease) in Invested Capital	-8.32	7.14	4.07	-0.49	-1.39	-4.02	4.16	12	-0.94	1.27	0.60
Enterprise Value (EV)	132	77	107	75	21	41	-4.85	1.19	33	12	26
Market Capitalization	151	87	128	78	29	51	34	16	36	13	23
Book Value per Share	$0.09	$0.30	$0.36	$0.04	$0.09	$0.53	$2.94	$1.94	$0.89	$0.58	$3.44
Tangible Book Value per Share	$0.07	$0.24	$0.35	$0.04	$0.09	$0.53	$2.94	$1.51	$0.51	$0.35	$1.94
Total Capital	8.89	13	28	7.71	9.54	7.51	39	32	19	18	13
Total Debt	0.08	6.79	6.97	4.98	2.74	3.08	1.99	6.08	6.08	5.10	4.06
Total Long-Term Debt	0.00	6.79	4.83	2.65	0.41	3.08	1.99	3.77	4.83	3.85	0.80
Net Debt	-19	-10	-21	-2.67	-8.13	-9.79	-38	-14	-2.56	-1.39	2.89
Capital Expenditures (CapEx)	1.49	1.10	0.46	0.13	0.06	0.00	0.06	0.18	0.16	0.04	0.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.89	-2.49	0.10	-0.44	2.44	0.58	0.53	3.62	4.70	6.06	7.50
Debt-free Net Working Capital (DFNWC)	17	14	28	7.22	13	13	41	24	13	13	8.67
Net Working Capital (NWC)	17	14	26	4.89	11	13	41	22	12	11	5.41
Net Nonoperating Expense (NNE)	4.50	4.16	6.99	8.07	0.48	6.52	0.08	4.19	4.62	4.01	2.37
Net Nonoperating Obligations (NNO)	-19	-10	-21	-2.67	-8.13	-9.79	-38	-14	-2.56	-1.39	2.89
Total Depreciation and Amortization (D&A)	0.90	1.82	1.75	1.67	0.69	0.62	1.02	0.89	1.70	1.61	1.57
Debt-free, Cash-free Net Working Capital to Revenue	-33.37%	-17.52%	1.33%	-3.84%	17.50%	6.58%	4.75%	28.04%	25.73%	33.82%	58.61%
Debt-free Net Working Capital to Revenue	192.38%	100.94%	379.59%	63.71%	95.62%	151.38%	364.04%	187.00%	72.99%	70.05%	67.75%
Net Working Capital to Revenue	191.46%	100.94%	350.50%	43.13%	78.86%	151.38%	364.04%	169.11%	66.15%	63.07%	42.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.60)	($28.05)	($12.30)	($6.60)	($2.55)	($2.21)	($0.80)	($1.16)	($1.10)	($8.40)	($4.91)
Adjusted Weighted Average Basic Shares Outstanding	6.82M	1.21M	2.37M	4.28M	5.80M	12.60M	12.19M	12.96M	13.87M	1.34M	2.43M
Adjusted Diluted Earnings per Share	($3.90)	($30.75)	($12.30)	($6.60)	($2.55)	($2.21)	($0.88)	($1.16)	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	6.82M	1.24M	2.37M	4.28M	5.80M	12.60M	12.27M	12.96M	17.90M	1.65M	3.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($6.60)	($2.55)	($2.21)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.24M	1.46M	4.01M	4.08M	4.79M	7.16M	12.69M	13.34M	17.90M	1.65M	3.56M
Normalized Net Operating Profit after Tax (NOPAT)	-15	-19	-22	-19	-12	-9.00	-9.68	-11	-11	-7.32	-9.33
Normalized NOPAT Margin	-174.26%	-135.79%	-294.67%	-166.97%	-83.69%	-101.34%	-86.07%	-84.33%	-57.87%	-40.85%	-72.88%
Pre Tax Income Margin	-226.19%	-165.04%	-396.06%	-238.19%	-87.17%	-178.17%	-86.82%	-116.79%	-83.14%	-63.21%	-91.37%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1,506.77	-1,466.63	-43.94	-43.99	-30.59	-112.85	-85.41	-95.67	-49.32	-41.12	-36.85
NOPAT to Interest Expense	-1,160.98	-1,206.89	-34.15	-31.54	-30.33	-66.93	-85.66	-69.80	-35.03	-27.22	-30.19
EBIT Less CapEx to Interest Expense	-1,621.54	-1,535.13	-44.65	-44.21	-30.75	-112.85	-85.93	-96.79	-49.84	-41.26	-37.46
NOPAT Less CapEx to Interest Expense	-1,275.75	-1,275.39	-34.85	-31.75	-30.49	-66.93	-86.18	-70.92	-35.55	-27.36	-30.80
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-0.74%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from ChronoScale Corporation Common Stock's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	13,806,950.00	14,234,818.00	17,903,128.00	18,174,426.00	18,444,181.00	21,998,369.00	24,824,762.00	29,042,975.00	2,611,788.00	-	3,563,381.00
DEI Adjusted Shares Outstanding	920,463.00	948,988.00	1,193,542.00	1,211,628.00	1,229,612.00	1,466,558.00	1,654,984.00	1,936,198.00	2,611,788.00	-	3,563,381.00
DEI Earnings Per Adjusted Shares Outstanding	-3.66	-3.39	-2.87	-1.99	-1.69	-2.33	-1.75	-1.40	-0.54	-	-1.93
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	38.39%	36.50%	-8.88%	5.25%	-10.38%	5.01%	-10.14%	-58.44%	2.37%	-38.31%	-36.56%
EBITDA Growth	29.86%	4.87%	23.22%	48.01%	44.87%	-8.80%	17.70%	-16.56%	34.68%	-37.65%	-157.60%
EBIT Growth	22.69%	-1.12%	21.16%	43.82%	39.62%	-6.51%	16.40%	-12.90%	29.60%	-34.76%	-139.16%
NOPAT Growth	19.79%	22.25%	26.80%	45.49%	9.96%	35.34%	-5.65%	-70.24%	46.87%	-102.20%	-63.31%
Net Income Growth	21.82%	-1.13%	21.87%	42.88%	38.43%	-6.19%	15.69%	-12.13%	31.42%	-36.95%	-138.15%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	24.02%	0.00%
Operating Cash Flow Growth	-29.46%	56.53%	17.75%	8.03%	32.09%	9.53%	43.31%	-28.99%	9.49%	-202.23%	-8.04%
Free Cash Flow Firm Growth	-92.34%	90.39%	84.50%	77.59%	82.50%	-92.41%	63.97%	52.12%	87.82%	-32.64%	95.03%
Invested Capital Growth	713.71%	-8.59%	-0.60%	9.67%	2.56%	12.62%	-14.52%	-12.76%	-6.03%	5.27%	-41.04%
Revenue Q/Q Growth	-2.04%	5.21%	-22.51%	31.79%	-16.59%	23.27%	-33.69%	-39.05%	105.49%	-25.72%	-31.82%
EBITDA Q/Q Growth	23.10%	5.56%	-9.16%	34.42%	18.46%	-86.38%	17.42%	7.13%	54.30%	-292.76%	-54.53%
EBIT Q/Q Growth	20.82%	4.60%	-7.08%	30.55%	14.90%	-68.29%	15.95%	6.21%	46.94%	-222.17%	-49.16%
NOPAT Q/Q Growth	31.58%	-17.67%	5.60%	28.29%	-13.02%	15.50%	-54.26%	-15.55%	64.73%	-221.61%	-24.60%
Net Income Q/Q Growth	20.45%	4.49%	-6.69%	29.54%	14.24%	-64.72%	15.29%	6.30%	47.55%	-228.92%	-47.30%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-15.50%	52.76%	-118.81%	22.97%	14.72%	37.07%	-37.12%	-75.27%	40.16%	-110.14%	50.98%
Free Cash Flow Firm Q/Q Growth	-2.79%	88.01%	-50.46%	-20.81%	19.73%	-31.87%	71.83%	-60.54%	79.57%	-1,335.46%	98.94%
Invested Capital Q/Q Growth	8.36%	-13.63%	10.41%	6.13%	1.34%	-5.16%	-16.20%	8.31%	9.16%	6.24%	-53.06%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.31%	48.88%	51.94%	53.27%	53.50%	53.32%	53.51%	39.82%	60.30%	53.22%	50.16%
EBITDA Margin	-62.45%	-56.06%	-78.97%	-39.29%	-38.41%	-58.07%	-72.33%	-110.21%	-24.51%	-129.59%	-293.69%
Operating Margin	-63.62%	-71.16%	-86.69%	-47.17%	-63.91%	-43.81%	-101.93%	-193.24%	-33.17%	-143.60%	-262.40%
EBIT Margin	-71.65%	-64.97%	-89.78%	-47.31%	-48.27%	-65.89%	-83.53%	-128.54%	-33.19%	-143.95%	-314.90%
Profit (Net Income) Margin	-73.04%	-66.31%	-91.29%	-48.81%	-50.18%	-67.05%	-85.66%	-131.70%	-33.62%	-148.85%	-321.58%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	101.94%	102.06%	101.69%	103.16%	103.96%	101.76%	102.55%	102.46%	101.28%	103.41%	102.12%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-115.77%	-86.53%	-97.67%	-53.27%	-67.13%	-51.45%	-121.64%	-179.77%	-29.59%	-110.76%	-281.79%
ROIC Less NNEP Spread (ROIC-NNEP)	-107.24%	-77.13%	-80.08%	-32.01%	-60.27%	42.44%	-105.96%	-195.41%	33.17%	-313.39%	-105.79%
Return on Net Nonoperating Assets (RNNOA)	75.30%	34.47%	29.63%	7.88%	13.12%	-6.61%	24.42%	7.99%	-1.89%	-21.60%	19.26%
Return on Equity (ROE)	-40.47%	-52.06%	-68.03%	-45.39%	-54.01%	-58.07%	-97.22%	-171.78%	-31.48%	-132.36%	-262.53%
Cash Return on Invested Capital (CROIC)	-328.72%	-91.56%	-86.95%	-83.66%	-71.90%	-80.40%	-56.75%	-64.36%	-60.59%	-85.44%	-92.32%
Operating Return on Assets (OROA)	-34.52%	-34.02%	-48.69%	-28.18%	-28.26%	-42.51%	-52.09%	-75.10%	-19.25%	-78.80%	-155.04%
Return on Assets (ROA)	-35.19%	-34.72%	-49.51%	-29.08%	-29.39%	-43.26%	-53.42%	-76.95%	-19.49%	-81.48%	-158.33%
Return on Common Equity (ROCE)	-40.47%	-52.06%	-68.03%	-45.39%	-54.01%	-58.07%	-97.22%	-171.78%	-31.48%	-132.36%	-210.55%
Return on Equity Simple (ROE_SIMPLE)	-99.38%	0.00%	-101.33%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.05	-2.41	-2.28	-1.63	-1.85	-1.56	-2.41	-2.78	-0.98	-3.16	-3.93
NOPAT Margin	-44.53%	-49.81%	-60.68%	-33.02%	-44.74%	-30.67%	-71.35%	-135.27%	-23.22%	-100.52%	-183.68%
Net Nonoperating Expense Percent (NNEP)	-8.53%	-9.41%	-17.59%	-21.26%	-6.85%	-93.89%	-15.68%	15.64%	-62.76%	202.63%	-176.00%
Return On Investment Capital (ROIC_SIMPLE)	-	-12.92%	-11.46%	-9.25%	-9.13%	-8.76%	-13.73%	-17.93%	-7.04%	-24.13%	-66.26%
Cost of Revenue to Revenue	46.69%	51.12%	48.06%	46.73%	46.50%	46.68%	46.49%	60.18%	39.70%	46.78%	49.84%
SG&A Expenses to Revenue	47.23%	52.01%	59.98%	40.61%	55.97%	43.52%	75.59%	109.48%	49.40%	98.57%	189.54%
R&D to Revenue	25.16%	27.11%	30.24%	22.55%	18.82%	16.60%	29.27%	41.42%	13.01%	20.41%	27.23%
Operating Expenses to Revenue	116.93%	120.03%	138.63%	100.44%	117.41%	97.13%	155.44%	233.06%	93.47%	196.82%	312.56%
Earnings before Interest and Taxes (EBIT)	-3.30	-3.15	-3.37	-2.34	-1.99	-3.35	-2.82	-2.64	-1.40	-4.52	-6.74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2.88	-2.72	-2.97	-1.95	-1.59	-2.96	-2.44	-2.27	-1.04	-4.07	-6.29
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.66	2.82	1.73	1.59	1.44	1.06	0.79	0.58	1.38	2.51	18.16
Price to Tangible Book Value (P/TBV)	1.03	4.89	2.77	2.78	2.19	1.74	1.26	1.02	2.63	4.45	0.00
Price to Revenue (P/Rev)	0.60	1.95	1.36	1.06	1.21	0.75	0.57	0.43	0.91	1.77	3.28
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.56	3.29	1.93	1.60	1.55	1.06	0.72	0.56	1.33	2.14	7.41
Enterprise Value to Revenue (EV/Rev)	0.38	1.81	1.19	1.04	1.04	0.67	0.39	0.39	1.01	2.00	3.58
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.41	0.48	0.42	0.46	0.36	0.40	0.38	0.42	0.44	0.45	0.67
Long-Term Debt to Equity	0.33	0.38	0.33	0.36	0.28	0.30	0.28	0.31	0.11	0.09	0.09
Financial Leverage	-0.70	-0.45	-0.37	-0.25	-0.22	-0.16	-0.23	-0.04	-0.06	0.07	-0.18
Leverage Ratio	1.61	1.84	1.87	2.04	2.00	2.20	2.10	2.18	2.07	2.15	2.55
Compound Leverage Factor	1.64	1.87	1.90	2.11	2.08	2.23	2.16	2.24	2.10	2.22	2.60
Debt to Total Capital	29.28%	32.54%	29.37%	31.72%	26.48%	28.66%	27.64%	29.55%	30.55%	31.00%	40.11%
Short-Term Debt to Total Capital	5.79%	6.69%	6.28%	7.08%	6.18%	7.02%	7.13%	8.06%	22.87%	24.90%	34.69%
Long-Term Debt to Total Capital	23.48%	25.86%	23.09%	24.64%	20.30%	21.64%	20.51%	21.50%	7.68%	6.10%	5.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	38.08%
Common Equity to Total Capital	70.72%	67.46%	70.63%	68.28%	73.52%	71.34%	72.36%	70.45%	69.45%	69.00%	21.80%
Debt to EBITDA	-0.47	-0.46	-0.48	-0.53	-0.58	-0.54	-0.54	-0.50	-0.49	-0.41	-0.28
Net Debt to EBITDA	0.27	0.19	0.24	0.03	0.32	0.15	0.36	0.07	-0.18	-0.29	0.01
Long-Term Debt to EBITDA	-0.38	-0.37	-0.37	-0.41	-0.45	-0.41	-0.40	-0.36	-0.12	-0.08	-0.04
Debt to NOPAT	-0.56	-0.57	-0.60	-0.67	-0.66	-0.70	-0.65	-0.53	-0.55	-0.43	-0.35
Net Debt to NOPAT	0.32	0.24	0.30	0.03	0.36	0.19	0.43	0.08	-0.20	-0.31	0.01
Long-Term Debt to NOPAT	-0.45	-0.46	-0.47	-0.52	-0.50	-0.53	-0.48	-0.39	-0.14	-0.09	-0.05
Altman Z-Score	-9.46	-9.49	-9.97	-11.07	-10.01	-11.81	-11.78	-14.44	-15.19	-16.82	-17.77
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	19.80%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.85	2.49	2.81	2.42	2.81	2.50	2.35	2.38	1.66	1.63	1.55
Quick Ratio	2.02	1.76	1.99	1.61	2.03	1.56	1.70	1.46	0.98	0.98	0.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-12	-1.47	-2.21	-2.67	-2.15	-2.83	-0.80	-1.28	-0.26	-3.75	-0.04
Operating Cash Flow to CapEx	-19,723.53%	-3,683.72%	-43,325.00%	0.00%	-28,462.50%	-6,823.81%	-19,650.00%	-8,610.00%	-17,175.00%	-3,437.30%	0.00%
Free Cash Flow to Firm to Interest Expense	-191.53	-22.62	-38.81	-36.11	-27.16	-47.95	-11.07	-19.68	-14.52	-24.37	-0.28
Operating Cash Flow to Interest Expense	-52.39	-24.37	-60.81	-36.08	-28.82	-24.29	-27.29	-52.98	-114.50	-28.12	-14.85
Operating Cash Flow Less CapEx to Interest Expense	-52.66	-25.03	-60.95	-36.08	-28.92	-24.64	-27.43	-53.60	-115.17	-28.94	-14.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.48	0.52	0.54	0.60	0.59	0.65	0.62	0.58	0.58	0.55	0.49
Accounts Receivable Turnover	3.66	3.56	3.38	3.14	2.75	2.78	2.87	2.65	2.27	1.76	2.10
Inventory Turnover	1.91	1.80	1.65	1.65	1.62	1.75	1.62	1.36	1.36	1.27	1.13
Fixed Asset Turnover	11.15	7.78	8.30	8.96	9.52	9.97	10.59	9.21	10.30	8.93	9.02
Accounts Payable Turnover	3.52	3.68	3.61	3.31	3.95	4.95	4.22	3.98	3.96	3.99	2.65
Days Sales Outstanding (DSO)	99.63	102.54	107.99	116.29	132.49	131.17	127.22	137.68	161.01	207.41	173.49
Days Inventory Outstanding (DIO)	190.99	203.07	221.23	220.66	225.40	208.68	224.68	267.55	267.43	287.91	321.72
Days Payable Outstanding (DPO)	103.81	99.15	101.04	110.16	92.36	73.72	86.47	91.80	92.27	91.43	137.51
Cash Conversion Cycle (CCC)	186.81	206.46	228.18	226.79	265.53	266.12	265.42	313.42	336.17	403.89	357.70
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	12	10	11	12	12	11	9.49	10	11	12	5.59
Invested Capital Turnover	2.60	1.74	1.61	1.61	1.50	1.68	1.70	1.33	1.27	1.10	1.53
Increase / (Decrease) in Invested Capital	10	-0.94	-0.07	1.04	0.30	1.27	-1.61	-1.50	-0.72	0.60	-3.89
Enterprise Value (EV)	6.50	33	21	19	18	12	6.80	5.71	15	26	41
Market Capitalization	10	36	24	19	21	13	10	6.37	13	23	38
Book Value per Share	$1.11	$0.89	$0.78	$0.66	$0.81	$0.58	$0.51	$0.38	$3.71	$3.44	$0.59
Tangible Book Value per Share	$0.71	$0.51	$0.49	$0.38	$0.53	$0.35	$0.32	$0.22	$1.95	$1.94	($0.49)
Total Capital	22	19	20	18	20	18	18	16	14	13	9.59
Total Debt	6.32	6.08	5.84	5.60	5.36	5.10	4.85	4.59	4.26	4.06	3.85
Total Long-Term Debt	5.07	4.83	4.59	4.35	4.11	3.85	3.60	3.34	1.07	0.80	0.52
Net Debt	-3.62	-2.56	-2.96	-0.28	-2.94	-1.39	-3.21	-0.66	1.54	2.89	-0.15
Capital Expenditures (CapEx)	0.02	0.04	0.01	0.00	0.01	0.02	0.01	0.04	0.01	0.13	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	5.84	4.70	5.66	6.30	6.52	6.06	4.71	5.27	6.32	7.50	4.29
Debt-free Net Working Capital (DFNWC)	16	13	14	12	15	13	13	11	9.04	8.67	8.29
Net Working Capital (NWC)	15	12	13	11	14	11	12	9.26	5.86	5.41	4.96
Net Nonoperating Expense (NNE)	1.31	0.80	1.15	0.78	0.22	1.85	0.48	-0.07	0.44	1.52	2.95
Net Nonoperating Obligations (NNO)	-3.62	-2.56	-2.96	-0.28	-2.94	-1.39	-3.21	-0.66	1.54	2.89	-0.15
Total Depreciation and Amortization (D&A)	0.42	0.43	0.41	0.40	0.41	0.40	0.38	0.38	0.37	0.45	0.45
Debt-free, Cash-free Net Working Capital to Revenue	34.39%	25.73%	31.57%	34.71%	36.86%	33.82%	26.85%	35.96%	42.86%	58.61%	37.13%
Debt-free Net Working Capital to Revenue	92.90%	72.99%	80.69%	67.11%	83.76%	70.05%	72.76%	71.74%	61.32%	67.75%	71.66%
Net Working Capital to Revenue	85.54%	66.15%	73.71%	60.23%	76.69%	63.07%	65.64%	63.20%	39.71%	42.29%	42.91%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.24)	($0.22)	($0.20)	($1.95)	($1.50)	($38.10)	($1.80)	($1.24)	($0.54)	($1.93)	($2.04)
Adjusted Weighted Average Basic Shares Outstanding	14.07M	13.87M	17.42M	1.21M	1.35M	89.60K	1.69M	2.18M	2.62M	2.43M	3.56M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($38.10)	$0.00	$0.00	$0.00	($1.93)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	14.23M	17.90M	18.17M	1.23M	1.47M	1.65M	1.94M	2.61M	2.62M	3.56M	3.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($38.10)	$0.00	$0.00	$0.00	($1.93)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	14.23M	17.90M	18.17M	1.23M	1.47M	1.65M	1.94M	2.61M	2.62M	3.56M	3.56M
Normalized Net Operating Profit after Tax (NOPAT)	-2.05	-2.41	-2.28	-1.63	-1.85	-1.56	-2.41	-2.78	-0.98	-3.16	-3.93
Normalized NOPAT Margin	-44.53%	-49.81%	-60.68%	-33.02%	-44.74%	-30.67%	-71.35%	-135.27%	-23.22%	-100.52%	-183.68%
Pre Tax Income Margin	-73.04%	-66.31%	-91.29%	-48.81%	-50.18%	-67.05%	-85.66%	-131.70%	-33.62%	-148.85%	-321.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-51.58	-48.45	-59.16	-31.65	-25.23	-56.85	-39.15	-40.68	-77.94	-29.35	-47.15
NOPAT to Interest Expense	-32.06	-37.14	-39.99	-22.09	-23.38	-26.46	-33.44	-42.81	-54.52	-20.50	-27.50
EBIT Less CapEx to Interest Expense	-51.84	-49.11	-59.30	-31.65	-25.33	-57.20	-39.29	-41.29	-78.61	-30.17	-47.15
NOPAT Less CapEx to Interest Expense	-32.32	-37.80	-40.13	-22.09	-23.48	-26.81	-33.58	-43.42	-55.19	-21.31	-27.50
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

ChronoScale Corporation (NASDAQ: CHRN) continues to operate with significant losses and weak operating cash flow, but the latest quarter showed a better cash balance and some improvement in equity compared with prior periods.

For Q1 2026, the company reported revenue of $2.1 million, down from $3.1 million in Q4 2025 and $3.4 million in Q1 2025. Gross profit also declined to $1.1 million, while operating expenses remained high at $6.7 million. That produced an operating loss of $5.6 million and a net loss of $6.9 million, or $2.04 per share.

The longer trend is also challenging. Revenue has generally moved lower over the last four quarters, falling from $4.2 million in Q3 2025 and $5.1 million in Q4 2024 to the current level. At the same time, the company has continued to post sizable quarterly net losses, showing that expense control has not yet caught up with the revenue base.

Cash flow remains a concern. In Q1 2026, operating activities used $2.1 million of cash, continuing a pattern of negative operating cash flow. The company did not spend on capex this quarter, but it still relied on financing activity to end the period with a healthier cash position. Cash and equivalents rose to $4.0 million from $2.7 million at the end of Q3 2025.

The balance sheet is mixed. Total assets were $19.7 million and total liabilities were $13.9 million, leaving common equity of just $2.1 million. That is a meaningful improvement from the $9.7 million common equity reported in Q3 2025, but the company still carries a relatively heavy liability load for its size, including $3.3 million of short-term debt and $5.2 million of long-term debt.

Cash improved sequentially, rising to $4.0 million at the end of Q1 2026 from $2.7 million in Q3 2025.
Capex was minimal, with no property, plant and equipment purchases in Q1 2026, helping preserve cash.
Common equity improved quarter over quarter to $2.1 million from $9.7 million in Q3 2025 after a much weaker Q4 2025 balance sheet profile.
Deferred revenue remains material, which can support future revenue recognition if the company delivers on orders and services.
Gross profit is still positive, showing the core product business generates some margin before overhead costs.
Interest expense is relatively small compared with the operating loss, so the main issue is operations rather than financing costs alone.
Revenue declined sharply to $2.1 million in Q1 2026, down from $3.1 million in Q4 2025 and $3.4 million in Q1 2025.
Operating losses remain very large, with Q1 2026 operating loss of $5.6 million against just $2.1 million in revenue.
Operating cash flow was negative by $2.1 million in Q1 2026, indicating the business is still burning cash.
The balance sheet remains leveraged with $8.5 million of total debt and only $2.1 million of common equity.

Bottom line: CHRN is still in a turnaround phase. The company has some liquidity and gross profit, but the combination of declining revenue, persistent losses, and negative operating cash flow suggests investors should remain cautious until there is clearer evidence of sustained top-line growth and expense improvement.

07/16/26 11:36 PM ETAI Generated. May Contain Errors.

ChronoScale Corporation Common Stock Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ChronoScale Corporation Common Stock's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

ChronoScale Corporation Common Stock's net income appears to be on a downward trend, with a most recent value of -$11.70 million in 2025, falling from -$19.59 million in 2015. The previous period was -$11.33 million in 2024. See ChronoScale Corporation Common Stock's forecast for analyst expectations on what's next for the company.

ChronoScale Corporation Common Stock's total operating income in 2025 was -$13.33 million, based on the following breakdown:

Total Gross Profit: $6.85 million
Total Operating Expenses: $20.17 million

Over the last 10 years, ChronoScale Corporation Common Stock's total revenue changed from $8.66 million in 2015 to $12.80 million in 2025, a change of 47.8%.

ChronoScale Corporation Common Stock's total liabilities were at $11.08 million at the end of 2025, a 20.5% decrease from 2024, and a 52.6% decrease since 2015.

In the past 10 years, ChronoScale Corporation Common Stock's cash and equivalents has ranged from $0.00 in 2021 to $27.81 million in 2017, and is currently $1.17 million as of their latest financial filing in 2025.

Over the last 10 years, ChronoScale Corporation Common Stock's book value per share changed from 0.09 in 2015 to 3.44 in 2025, a change of 3,892.1%.

Related Companies

Financial statements for NASDAQ:CHRN last updated on 7/15/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ChronoScale Corporation Common Stock (CHRN) Financials

Financials Breakdown Chart

Key Financial Trends

ChronoScale Corporation Common Stock Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ChronoScale Corporation Common Stock (CHRN) Financials

Annual Income Statements for ChronoScale Corporation Common Stock

Quarterly Income Statements for ChronoScale Corporation Common Stock

Annual Cash Flow Statements for ChronoScale Corporation Common Stock

Quarterly Cash Flow Statements for ChronoScale Corporation Common Stock

Annual Balance Sheets for ChronoScale Corporation Common Stock

Quarterly Balance Sheets for ChronoScale Corporation Common Stock

Annual Metrics And Ratios for ChronoScale Corporation Common Stock

Quarterly Metrics And Ratios for ChronoScale Corporation Common Stock

Financials Breakdown Chart

Key Financial Trends

ChronoScale Corporation Common Stock Financials - Frequently Asked Questions

When does ChronoScale Corporation Common Stock's financial year end?

How has ChronoScale Corporation Common Stock's net income changed over the last 10 years?

What is ChronoScale Corporation Common Stock's operating income?

How has ChronoScale Corporation Common Stock's revenue changed over the last 10 years?

How much debt does ChronoScale Corporation Common Stock have?

How much cash does ChronoScale Corporation Common Stock have?

How has ChronoScale Corporation Common Stock's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools